Version 2.36 of HDC Discover was rolled out to production on January 23rd, 2024.  Please do not hesitate to contact our support email support@hdcbc.ca should you have any questions or comments about any of these changes.

What’s New? 

  • We are introducing two new chronic disease prevalence measures listed below for all EMRs:
Measure  MOIS  OSCAR  Profile  Med Access  Med Access – Legacy  Wolf 
Chronic disease prevalence – One or more  NEW  NEW  NEW  NEW  NEW  NEW 
Chronic disease prevalence – Two or more  NEW  NEW  NEW  NEW  NEW  NEW 

Improvements 

  • Updates have been applied to this measure name and description for increased accuracy: 
Measure  New Measure Name  New Measure Description 
Heart failure patients prescribed with ACE inhibitor or ARB in the past year  Heart failure patients prescribed a RAAS inhibitor in the past year  The percentage of active patients with Heart Failure (HF) (based on the problem list) that have had a coded prescription for a Renin-angiotensin-aldosterone system (RAAS) inhibitor (including ACE Inhibitors and Angiotensin II antagonists) in the past year recorded in the EMR. 
  • “Hypertension” and “Mood Disorder concepts 

Following user feedback, we have refined our concepts related to “Hypertension” and “Mood Disorder” to enhance precision. Consequently, users of MOIS and Med Access may observe a decrease in the reported prevalence of Hypertension and Mood Disorder in their practice. 

  • Medication Prescribing Measures

We have improved our concepts related to Medication Prescribing measures to enhance precision. Consequently, users may observe a change in their Medication Prescribing measures.